For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
Scope of the Report:
This report focuses on the Pain Management Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of pain management drugs includes opioids, NSAIDs and other types, and the proportion of opioids is about 47% in 2016, and the proportion is in decreasing trend from 2012 to 2017.
North America is the largest consumption place, with a consumption market share nearly 37% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is intense. Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Pain Management Drugs is expected to grow at a CAGR of roughly 2.8% over the next five years, will reach 41900 million US$ in 2023, from 35600 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Eli Lilly
- Yunnan Baiyao
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Generic Opioids
- Branded Opioids
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Pain Management Drugs market.
Chapter 1, to describe Pain Management Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pain Management Drugs, with sales, revenue, and price of Pain Management Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pain Management Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pain Management Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pain Management Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source